Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands.  Tenofovir or adefovir for hepatitis B.
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000302:isolation & purification; D006801:Humans; D063065:Organophosphonates / Q000627:therapeutic use*; D000068698:Tenofovir; D019562:Viral Load
D000998:Antiviral Agents; D063065:Organophosphonates; C053001:adefovir; D000068698:Tenofovir; D000225:Adenine